Hezi Himelfarb
Chief Executive Officer bei ClearCut Medical Ltd.
Profil
Yehezkel Himelfarb is currently the Chief Executive Officer of ClearCut Medical Ltd.
He previously served as the Chief Executive Officer of Remon Medical Technologies, Inc. from 1999 to 2008, and as the Chief Executive Officer & Director of IceCure Medical Ltd.
from 2008 to 2016.
From 2016 to 2019, he was the Chief Operating Officer, Director & GM of Microbot Medical, Inc. Himelfarb also held positions as Principal at Medtronic Instent, Inc. and Suny Cellular Communication Ltd.
Himelfarb received his undergraduate and MBA degrees from Tel-Aviv University.
Aktive Positionen von Hezi Himelfarb
| Unternehmen | Position | Beginn |
|---|---|---|
ClearCut Medical Ltd.
 ClearCut Medical Ltd. Medical SpecialtiesHealth Technology ClearCut Medical Ltd. develops proprietary technology and tools for removal of cancer. Its product ClearSightTM MRI System, focuses on breast cancer lumpectomy for intraoperative margin assessment of surgically removed lumps. The firms applications include breast cancer biopsies, margin assessment of skin cancer, prostate cancer, colorectal cancer and lung cancer tissue microstructure. The company was founded by Eyal Kolka and Erez Golan in 2010 and is headquartered in Rehovot, Israel. | Chief Executive Officer | 21.03.2022 |
Ehemalige bekannte Positionen von Hezi Himelfarb
| Unternehmen | Position | Ende |
|---|---|---|
| MICROBOT MEDICAL INC. | Chief Operating Officer | 01.02.2019 |
| ICECURE MEDICAL LTD | Chief Executive Officer | 31.10.2016 |
Remon Medical Technologies, Inc.
 Remon Medical Technologies, Inc. Medical SpecialtiesHealth Technology Remon Medical Technologies, Inc. develops and commercializes assessment and treatment implants. It has developed applications for patient management, post-operative monitoring, nerve and tissue stimulation and local drug delivery. The company was founded by Eyal Doron, Yariv Porat and Yossi Tzaliach in 1997 and is headquartered in Waltham, MA. | Chief Executive Officer | 01.01.2008 |
| SUNY CELLULAR COMMUNICATION LTD | Corporate Officer/Principal | - |
Medtronic Instent, Inc.
 Medtronic Instent, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Medtronic Instent, Inc. is a private company that designs, develops, manufactures and markets stents. The company is based in Eden Prairie, MN. | Corporate Officer/Principal | - |
Ausbildung von Hezi Himelfarb
| Tel-Aviv University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SUNY CELLULAR COMMUNICATION LTD | Distribution Services |
| ICECURE MEDICAL LTD | Health Technology |
| MICROBOT MEDICAL INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Medtronic Instent, Inc.
Medtronic Instent, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Medtronic Instent, Inc. is a private company that designs, develops, manufactures and markets stents. The company is based in Eden Prairie, MN. | Health Technology |
Remon Medical Technologies, Inc.
Remon Medical Technologies, Inc. Medical SpecialtiesHealth Technology Remon Medical Technologies, Inc. develops and commercializes assessment and treatment implants. It has developed applications for patient management, post-operative monitoring, nerve and tissue stimulation and local drug delivery. The company was founded by Eyal Doron, Yariv Porat and Yossi Tzaliach in 1997 and is headquartered in Waltham, MA. | Health Technology |
ClearCut Medical Ltd.
ClearCut Medical Ltd. Medical SpecialtiesHealth Technology ClearCut Medical Ltd. develops proprietary technology and tools for removal of cancer. Its product ClearSightTM MRI System, focuses on breast cancer lumpectomy for intraoperative margin assessment of surgically removed lumps. The firms applications include breast cancer biopsies, margin assessment of skin cancer, prostate cancer, colorectal cancer and lung cancer tissue microstructure. The company was founded by Eyal Kolka and Erez Golan in 2010 and is headquartered in Rehovot, Israel. | Health Technology |
